Last reviewed · How we verify
NCT03740438
Modeling of the Hemoglobin Drop in the Uncomplicated Postoperative Course
trial testing Hemoglobin concentration in Surgical Blood Loss in 154 participants. Completed in 2 September 2023.
1 September 2023
Quick facts
| Lead sponsor | Hospital Clinic of Barcelona |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 154 |
| Start date | 1 September 2018 |
| Primary completion | 1 September 2023 |
| Estimated completion | 2 September 2023 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Hemoglobin concentration
Conditions studied
- Surgical Blood Loss — all drugs for Surgical Blood Loss →
- Surgery — all drugs for Surgery →
- Perioperative/Postoperative Complications — all drugs for Perioperative/Postoperative Complications →
Sponsor
Hospital Clinic of Barcelona
Who can join
18 and older, any sex, with Surgical Blood Loss or Surgery. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
transfusion-related decisions in the perioperative setting are often complex due to acute variations in the hemoglobin levels, which typically experience a progressive decrease within days. This process, commonly referred to as "hemoglobin drop" or "hemoglobin drift", has been observed to be highly variable among patients and reliant on several variables, such as the volemic status, fluid balance and blood loss. Although it has been investigated and some predictors have been identified, postoperative hemoglobin drop remains unpredictable and is not fully clarified. In consequence, hemoglobin levels' variations are frequently misunderstood, hindering the decision to transfuse.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03740438
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Surgical Blood Loss
Currently open trials in the same condition.
- NCT06414031 — Tranexamic Acid for Reduction of Transfusion in Abdominal Surgery · Phase 3 · recruiting
- NCT06164769 — Enucleation of Pancreatic Tumor by Blocking Abdominal Trunk and Superior Mesenteric Artery · NA · recruiting
Other Hospital Clinic of Barcelona trials
Trials by the same sponsor.
- NCT07509814 — Extended Versus Short Prehabilitation Programme for Patients With Advanced Ovarian Cancer Undergoing Major Surgery · NA · not yet recruiting
- NCT07469358 — iCBT for Adolescents Obsessive-compulsive Dissorder · NA · active not recruiting
- NCT07358611 — Non-invasive Mapping-Guided Atrial Fibrillation Ablation · NA · recruiting
- NCT07237867 — Frequency-Dependent Effects of Percutaneous Femoral Nerve Stimulation on Quadriceps Strength in Athletes With Patellar T · NA · recruiting
- NCT07163936 — Analysis of the Influence of Dialysis Fluid Composition on Vascular Calcification in Patients With Chronic Kidney Diseas · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03740438 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hospital Clinic of Barcelona
- Last refreshed: 29 October 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03740438.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing